Please ensure Javascript is enabled for purposes of website accessibility
Home > Products > Recombinant Proteins > Cytokines and Growth Factors

Recombinant Human IL17A Protein, C-His (HS856011)

Recombinant Human IL17A Protein, C-His
Recombinant Human IL17A Protein, C-His
Recombinant Human IL17A Protein, C-His
Recombinant Human IL17A Protein, C-His
Recombinant Human IL17A Protein, C-His
Recombinant Human IL17A Protein, C-His
Recombinant Human IL17A Protein, C-His
Recombinant Human IL17A Protein, C-His
Recombinant Human IL17A Protein, C-His
Recombinant Human IL17A Protein, C-His
Recombinant Human IL17A Protein, C-His
Recombinant Human IL17A Protein, C-His
Recombinant Human IL17A Protein, C-His
Recombinant Human IL17A Protein, C-His
Recombinant Human IL17A Protein, C-His
Recombinant Human IL17A Protein, C-His
Price(USD): $
Spec:
  • 50ug
  • 100ug
  • 1mg
Number:
Contact us
  • Overview

  • Images

  • References

  • Datasheet

Overview
Catalog No.HS856011
Description
Recombinant Human IL17A Protein, C-His (HS856011) expressed in Mammalian Cells, spanning Gly24-Ala155. Purity: >90% by SDS-PAGE.
Highlights
  • His-Tagged — N-terminal 6×His tag for IMAC purification.
  • Mammalian Expression — Proper folding and native glycosylation.
  • High Purity — >90% purity verified by SDS-PAGE.
Expression systemMammalian Cells
AccessionQ16552
Protein lengthGly24-Ala155
ApplicationsELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
SpeciesHomo sapiens (Human)
Nature Recombinant
Endotoxin level Please contact with the lab for this information.
Purity >90% as determined by SDS-PAGE.
Predicted molecular weight 18.45 kDa
Form Lyophilized
Storage buffer Lyophilized from a solution in PBS pH 7.4, 1 mM EDTA, 4% Trehalose, 1% Mannitol.

Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA.

Reconstitution Reconstitute in sterile water for a stock solution. Adjust the volume of sterile water so that, after reconstitution, the final stock concentration matches the value indicated on the product label or datasheet.

RECONSTITUTION PROTOCOL
1. Allow the product to be reconstituted and the reconstitution diluent to reach room temperature.
2. Tap or briefly centrifuge the product vial before opening to dislodge any lyophilized material that may be dispersed on the wall or cap of the vial.
3. Use the diluent and stock concentration recommended in the product datasheet. If preparing a stock concentration higher than recommended, contact Technical Service.
4. After adding the diluent, re-cap the vial and invert gently by hand or place on a slow rocking platform to allow the reconstitution diluent to coat all the surfaces inside the vial. Note: Do not mix by vortexing or by pipetting the material up and down.
5. Allow the vial to sit at room temperature with gentle agitation for at least 15 minutes before aliquotting or using.
6. Store the reconstituted material in single use aliquots in polypropylene or siliconized tubes. Aliquots of 10 μL or larger are recommended.
Shipping In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.
Stability and Storage Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Alternate NamesCTLA-8, Cytotoxic T-lymphocyte-associated antigen 8, IL17, IL-17A, IL17A, CTLA8, IL-17, Interleukin-17A
Background

Interleukin-17A (IL17A) is a ~17 kDa protein. Effector cytokine of innate and adaptive immune system involved in antimicrobial host defense and maintenance of tissue integrity. Signals via IL17RA-IL17RC heterodimeric receptor complex, triggering homotypic interaction of IL17RA and IL17RC chains with TRAF3IP2 adapter. This leads to downstream TRAF6-mediated activation of NF-kappa-B and MAPkinase pathways ultimately resulting in transcriptional activation of cytokines, chemokines, antimicrobial peptides and matrix metalloproteinases, with potential strong immune inflammation. Plays an important role in connecting T cell-mediated adaptive immunity and acute inflammatory response to destroy extracellular bacteria and fungi. As a signature effector cytokine of T-helper 17 cells (Th17), primarily induces neutrophil activation and recruitment at infection and inflammatory sites. IL17A is the therapeutic target of secukinumab (Cosentyx).

1. Boisson, B. et al. (2013) Immunity 39, 676-86. PMID: 24120361
2. Kuestner, RE. et al. (2007) Journal of immunology (Baltimore, Md. : 1950) 179, 5462-73. PMID: 17911633
3. Wright, JF. et al. (2008) Journal of immunology (Baltimore, Md. : 1950) 181, 2799-805. PMID: 18684971
4. Liu, C. et al. (2009) Science signaling 2, ra63. PMID: 19825828
5. Puel, A. et al. (2011) Science (New York, N.Y.) 332, 65-8. PMID: 21350122
6. Fossiez, F. et al. (1996) The Journal of experimental medicine 183, 2593-603. PMID: 8676080
Note For research use only.
Images
  • Recombinant Human IL17A Protein, C-His

    SDS-PAGE

    SDS-PAGE for Recombinant Human IL17A Protein, C-His

  • Recombinant Human IL17A Protein, C-His

    Bioactivity

    Detects Afasevikumab in indirect ELISAs.

  • Recombinant Human IL17A Protein, C-His

    Bioactivity

    Detects Remtolumab in indirect ELISAs.

  • Recombinant Human IL17A Protein, C-His

    Western blot

    Detected by Anti-IL17A monoclonal antibody (Catalog No: HV974026)

  • Recombinant Human IL17A Protein, C-His

    Western blot

    Detected by Anti-IL17A monoclonal antibody (Catalog No: HV243010)

  • Recombinant Human IL17A Protein, C-His

    Bioactivity

    Detected by Research Grade Xeligekimab (Catalog No: HS856116) in indirect ELISA

  • Recombinant Human IL17A Protein, C-His

    Bioactivity

    Detected by Research Grade Gumokimab (Catalog No: HS856126) in indirect ELISA

  • Recombinant Human IL17A Protein, C-His

    Bioactivity

    Detected by Roconkibart (Catalog No: HS856216) in indirect ELISA.

Formula
Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)
Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.
Mass
=
Concentration
×
Volume
Molecular Weight *
g/mol
Formula
C₁ × V₁ = C₂ × V₂
Enter any 3 of the 4 values to solve for the unknown.
Stock Solution
C₁ (Stock Conc.)
×
V₁ (Stock Vol.)
=
Working Solution
C₂ (Working Conc.)
×
V₂ (Working Vol.)
Recommendation

Contact us for custom quotes, bulk requests and any other issues.

Mail: support@abinScience.com

Distributor list